| Moffitt

The Gift of Going Home for the Holidays

Patient gets Christmas homecoming following bone marrow transplant, treatment for leukemia

USF Alumni Scores Game Ball During Continued Fight with Blood Cancer

Woman, 36, with slight exhaustion went in for routine physical and came out with cancer diagnosis

Hematologist Trains at Moffitt, Hoping to Benefit Armenians

Through a visiting physician program, a doctor is learning the intricacies of an allogeneic BMT procedure and care to help his home country

$Donor CAR T May Increase Remission in Relapsed or Refractory AML Patients$

Donor CAR T May Increase Remission in Relapsed or Refractory AML Patients

Good clinical responses seen for using genetically modified product

Moffitt Investigates First-of-Its-Kind Cellular Therapy in MDS Patients

Novel approach uses mismatched donor lymphocytes to activate patient’s immune system

Veteran Inspires Others to ‘Keep Fighting’ After Leukemia Diagnosis

Air Force combat medic now in remission after treatment for acute myeloid leukemia at Moffitt

Former Tour de France Champion Greg LeMond Reveals Leukemia Diagnosis

Chronic myelogenous leukemia is treatable, but not yet curable

Highlighting Moffitt’s Top 5 Research Stories of 2021

FDA approvals and COVID vaccine in cancer patients study showcase ability to translate discoveries into new therapies

Are Cancer Patients Responding to the COVID Vaccine?

Moffitt study shows patients with myeloid malignancies do develop antibodies after vaccination

WrestleMania’s Defending Champion Roman Reigns Talks About Smacking Down Cancer

WWE superstars step out of the ring to spend time with health care heroes

New Combo Therapy May Be a Better Option for Patients with Specific Mutation

Adding eprenetapopt to a standard MDS treatment shows promise in patients with TP53 mutations

Can UltraCAR-T™ Treat Myeloid Malignancies?

New type of CAR T therapy gets engineered cells to patients quicker

CAR T Brings Hope for Leukemia Patients, Challenges for Researchers

Phase 1 THINK study laid important groundwork for future CAR T trials

New Combination Therapy Shows Promise for Leukemia Patients

Early phase trial finds magrolimab plus chemotherapy effective in acute myeloid leukemia patients

‘I Spent A Decade Battling Cancer’

How one young woman thrived despite three separate cancer diagnoses

The Milestones Behind Miles for Moffitt

How three friends sparked an annual tradition for thousands Social Caption: In 15 years, Miles for Moffitt has become a staple in the Tampa Bay com ...

Rethinking Cellular Immunotherapy

Moffitt study uses CAR T therapy to treat side effects of cancer therapy

Sister, Sister

Bonds beyond DNA help sisters through transplant at Moffitt

With Leukemia in Remission, Roman Reigns Returns to WWE

The WWE Superstar announced this week that he is ready to step back into the ring.

Why I Ride: Gratitude for a Life-Saving Gift

For Cure on Wheels Co-Founder Richard Spayde, the organization and Capitol Ride are way of saying 'Thanks'

CAR T Provides Remission, Purpose for Moffitt Leukemia Patient

For CAR T treatment, T cells are removed from a patient’s blood and sent to a lab where the cells are genetically modified to better enable them to id ...

Endeavor^®

Filter Features Results

21 Articles Found